| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |